JAK2 and cancer: Inhibition of key pro-survival signaling pathways such as PI3K/AKT/mTOR and JAK2/STAT3 is significant for systematically dismantling the defense mechanisms of cancer cells, exhibiting extensive cross-talk with mechanisms discussed in other sections.